An observational, multicenter, prospective cohort study to evaluate the safety and efficacy of Vildagliptin plus Metformin relative to vildagliptin dual therapy

Trial Profile

An observational, multicenter, prospective cohort study to evaluate the safety and efficacy of Vildagliptin plus Metformin relative to vildagliptin dual therapy

Active, no longer recruiting
Phase of Trial: Phase IV

Latest Information Update: 19 Jul 2017

At a glance

  • Drugs Metformin (Primary) ; Vildagliptin (Primary) ; Vildagliptin/metformin
  • Indications Type 2 diabetes mellitus
  • Focus Therapeutic Use
  • Acronyms China PDS
  • Most Recent Events

    • 19 Jul 2017 New trial record
    • 13 Jun 2017 Updated 6-month interim results presented at the 77th Annual Scientific Sessions of the American Diabetes Association.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top